The most common genetic alterations were c.1310_1313 delAAGA in the BRCA2 gene and c.5030_5033 delCTAA in the BRCA1 gene, which were found in 4% of the breast cancer patients and 20% of the ovarian cancer patients. This evidence concerns the gene BRCA1 and ovarian carcinoma.